126

Изучен состав фекальной кишечной микробиоты и маркеры воспаления ( ИЛ-6 и СРБ) у 35 больных с ХБП, находившихся в отделении нефрологии III клиники ТМА. У больных с ХБП наблюдается нарушение баланса кишечной микробиоты. При этом у обследованных больных было обнаружено повышение таких маркеров воспаления как СРБ, ИЛ-6, лейкоцитов.

  • Internet havola
  • DOI10.26739/2181-9300-2019-4-10
  • UzSCI tizimida yaratilgan sana 27-11-2019
  • O'qishlar soni 0
  • Nashr sanasi 25-07-2019
  • Asosiy tilRus
  • Sahifalar82-87
Русский

Изучен состав фекальной кишечной микробиоты и маркеры воспаления ( ИЛ-6 и СРБ) у 35 больных с ХБП, находившихся в отделении нефрологии III клиники ТМА. У больных с ХБП наблюдается нарушение баланса кишечной микробиоты. При этом у обследованных больных было обнаружено повышение таких маркеров воспаления как СРБ, ИЛ-6, лейкоцитов.

English

The composition of the fecal intestinal microbiota and inflammation markers (IL-6 and CRP) was studied in 35 patients with CKD who were in the nephrology department of the TMA clinic III. In patients with CKD, an imbalance of the intestinal microbiota is observed. At the same time, an increase in such inflammatory markers as CRP, IL-6, and leukocytes was found in the examined patients.

Ўзбек

ТТА клиникасининг нефрология бўлимида бўлган СБК билан оғриган беморларда ичак микробиотасининг ва яллиғланиш маркерларини (ИЛ-6 ва СРО ) таркиби ўрганилди. СБК бўлган беморларда ичак микробиотасининг мувозанати кузатилди. Шу билан бирга ўрганилаётган беморларда СРО, ИЛ-6 ва лейкоцит каби яллиғланиш белгиларининг кўпайиши кузатилди.

№ Muallifning F.I.Sh. Lavozimi Tashkilot nomi
1 OLIMKHONOVA K.N.
2 EGAMBERDIEVA D.A.
№ Havola nomi
1 1. Lin C.J., Chen H.H., Pan C.F., Chuang C.K., Wang T.J., Sun F.J. et al. P-Cresylsulfate and indoxyl sulfate level at different stages of chronic kidney disease. J. Clin. Lab. Anal- 2011, №25, 191-197.
2 2. Barreto F.C., Barreto D.V., Liabeuf S., Meert N., Glorieux G., Temmar M. et al. European UREMIC Toxin Work Group (EUTox). Serum indoxyl sulfate is associated with vascular disease and mortality in chronic kidney disease patients.Clin. J. Am. Soc. Nephrol. 2009 №4(10) Р.1551
3 3. Bammens B., Evenopoel P., Keuleers H., Verbeke K., Vanrenterghem Y. Free serum concentrations of the protein-bound retention solute p-cresol predict mortality in hemodialysis patients. Kidney Int. 2006 №69(6) ,1081-1087.
4 4. Wang Z., Klipfell E., Bennett B.J., Koeth R., Levison B.S., Dugar B. et al. Gut fl ora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature. 2011 №472(7341), 57—63.
5 5. Aronov P.A., Luo F.J., Plummer N.S., Quan Z., Holmes S., Hostetter T.H. et al. Colonic contribution to uremic solutes J. Am. Soc. Nephrol. 2011 № 22(9) ,1769— 1776.
6 6. Vaziri N.D., Wong J., Pahl M., Piceno Y.M., Yuan J., DeSantis T.Z. et al. Chronic kidney disease alters intestinal microbial fl ora. Kidney Int. 2013 №83(2), 308—315.
7 7. Wu I.W., Hsu K.H., Lee C.C., Sun C.Y., Hsu H.J., Tsai C.J. et al. PCresyl sulphate and indoxyl sulphate predict progression of chronic kidney disease. Nephrol. Dial. Transplant.2011 №26(3), 938—947.
8 8. Food and Agriculture Organization of the United Nations (FAO). Health and nutritional properties of probiotics in food including powder milk with live lactic acidbacteria. 2001 (Accessed 30 October 2013).
9 9. Krishnamurthy V.M., Wei G., Baird B.C., Murtaugh M., Chonchol M.B., Raphael K.L. et al. High dietary fi ber intake is associated with decreased infl ammation and all-cause mortality in patients with chronic kidney disease. Kidney Int. 2012 №-81(3), 300—306.
10 10.Delzenne N.M., Cani P.D., Daubioul C., Neyrinck A.M. Impact of inulin and oligofructose on gastrointestinal peptides. Br. J. Nutr. 2005-№93(Suppl.1), 157—161.
11 11.Delzenne N.M., Cani P.D., Daubioul C., Neyrinck A.M. Impact of inulin and oligofructose on gastrointestinal peptides. Br. J. Nutr. 2005 №93(Suppl.1) ,157—161.
12 12.Goraya N., Wesson D.E. Acid-base status and progression of Chronic kidney disease. Curr. Opin. Nephrol. Hypertens. 2012 №21(5), 552—556.
13 13.Konstantinov S.R., Smidt H., de Vos W.M., Bruijns S.C., Singh S.K., Valence F. et al. S layer protein A of Lactobacillus acidophilus NCFM regulates immature dendritic cell and T cell functions. Proc. Natl. Acad. Sci. U.S.A. 2008 №105(49), 19474—9.
14 14.Van Baarlen P., Troost F.J., van Hemert S., van der Meer C., de Vos W.M., de Groot P.J. et al. Differential NF-kappaB pathways induction by Lactobacillus plantarum in the duodenum of healthy humans correlating with immune tolerance. Proc. Natl. Acad. Sci. U.S.A. 2009 №106(7), 2371—6.
15 15.Hida M., Aiba Y., Sawamura S., Suzuki N., Satoh T., Koga Y. et al. Inhibition of the accumulation of uremic toxins in the blood and their precursors in the feces after oral administration of Lebenin, a lactic acid bacteria preparation, to uremic patients undergoing hemodialysis. Nephron.1996 №74(2), 349-355.
Kutilmoqda